Blog
RSS FeedPosted by Michael Wonder on 26 Apr 2017
Changes to pharmaceutical extension of term application procedures the latest front in the battle for savings in Australia’s health care budget
26 April 2017 - It’s no secret that the Australian Government is struggling to manage the cost of its health ...
Posted by Michael Wonder on 18 Apr 2017
Submissions received and TGA response: orphan drug program
18 April 2017 - The TGA would like to thank respondents who provided submissions in response to the October 2016 ...
Posted by Michael Wonder on 10 Apr 2017
QUT, MTPConnect and industry partnership will help to ensure Australia stays globally competitive
10 April 2017 - Medicines Australia warmly welcomes the commencement of The Bridge Program – an initiative of a consortium ...
Posted by Michael Wonder on 06 Apr 2017
AusBiotech says R&D Tax Incentive critical to 2030 Innovation Strategy
6 April 2017 - Preserving the R&D Tax Incentive will be top priority as AusBiotech coordinates comment for Innovation and ...
Posted by Michael Wonder on 21 Mar 2017
TGA seeks feedback on support needs for SMEs
21 March 2017 - The TGA is investigating ways that it might provide support for small and medium enterprises in ...
Posted by Michael Wonder on 17 Mar 2017
Expedited pathways for prescription medicines
17 March 2017 - The TGA would like to thank respondents who provided submissions in response to the October 2016 ...
Posted by Michael Wonder on 16 Mar 2017
Nine submissions done and two due by month end…
16 March 2017 - Industry advocacy at AusBiotech is in ‘top gear’ with nine submissions completed on behalf of members ...
Posted by Michael Wonder on 08 Mar 2017
Donald Trump's FDA plans could affect drug regulation in Australia, leading medic warns
9 March 2017 - Drug safety and regulation in Australia are under threat from US President Donald Trump, says leading ...
Posted by Michael Wonder on 21 Feb 2017
AusBiotech suggests FSANZ amend cost recovery plan
21 February 2017 - AusBiotech has responded to Food Standards Australia New Zealand (FSANZ) call for comment on the draft ...
Posted by Michael Wonder on 15 Feb 2017
Proposed changes to accessing unapproved therapeutic goods through the Authorised Prescriber and Special Access Schemes
15 February 2017 - The TGA is seeking comments from interested parties on the proposed changes to the Special Access Scheme ...
Posted by Michael Wonder on 12 Feb 2017
TGA approval timelines for new cancer medicines
13 February 2017 - The publication of submission dates in the TGA's Annual Report for 2016 enables more insightful analysis ...
Posted by Michael Wonder on 06 Feb 2017
Greg Hunt's innovation fund sent back to drawing board
5 February 2017 - Former industry minister Greg Hunt's $500 million national innovation fund has been sent back to the ...
Posted by Michael Wonder on 01 Feb 2017
Diabetes drug that cuts sugar will also reduce heart problems
2 February 2017 - Diabetes will no longer be a death sentence for many sufferers, with a drug often prescribed ...
Posted by Michael Wonder on 31 Jan 2017
Trump health pick Tom Price pressed over purchase of shares in ASX-listed biotech Innate
31 January 2017 - US Republican politician Tom Price got a privileged offer to buy an Australian biomedical stock at ...
Posted by Michael Wonder on 31 Jan 2017
Registration of new chemical entities in Australia (2016)
31 January 2017 - The TGA has published its annual summary for 2016. ...